Login

Willkomen zurück, bitte gebe deine Zugangsdaten ein!

Passwort vergessen

Anmeldung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

Healthy pregnancies and newborns are possible after CAR T cell therapy

Women who received treatment for autoimmune diseases with CAR T cell therapy went on to have regular pregnancies and healthy babies.

Videos

Ähnliche Seiten

https://moneycheck.com/moderna-mrna-stock-soars-13-on-new-car-t-therapy-announcement/

Moderna (MRNA) Stock Soars 13% on New CAR-T Therapy Announcement - MoneyCheck

https://moneycheck.com/moderna-mrna-stock-soars-13-on-new-car-t-therapy-announcement/
https://moneycheck.com/moderna-mrna-stock-soars-13-on-breakthrough-car-t-therapy-and-fda-vaccine-victory/

Moderna (MRNA) Stock Soars 13% on Breakthrough CAR-T Therapy and FDA Vaccine Victory - MoneyCheck

https://moneycheck.com/moderna-mrna-stock-soars-13-on-breakthrough-car-t-therapy-and-fda-vaccine-victory/
https://www.eurekalert.org/news-releases/1128603

Cytokine-armored CAR-T cell therapy helps eliminate aggressive brain tumors in preclinical study | EurekAlert!

https://www.eurekalert.org/news-releases/1128603
https://www.smithsonianmag.com/innovation/how-a-revolutionary-cancer-treatment-could-reset-the-immune-systems-of-patients-with-autoimmune-diseases-180988753/

How a Revolutionary Cancer Treatment Could Reset the Immune Systems of Patients With Autoimmune Diseases

https://www.smithsonianmag.com/innovation/how-a-revolutionary-cancer-treatment-could-reset-the-immune-systems-of-patients-with-autoimmune-diseases-180988753/
https://www.manilatimes.net/2026/07/16/tmt-newswire/globenewswire/umoja-biopharma-announces-fda-clearance-of-ind-application-for-ub-vv400-the-industrys-first-known-cd22-directed-in-vivo-car-t-cell-therapy-for-relapsedrefractory-b-cell-malignancies/2385835

Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV400, the Industry’s First Known CD22-Directed In Vivo CAR T Cell Therapy for Relapsed/Refractory B Cell Malignancies | The Manila...

https://www.manilatimes.net/2026/07/16/tmt-newswire/globenewswire/umoja-biopharma-announces-fda-clearance-of-ind-application-for-ub-vv400-the-industrys-first-known-cd22-directed-in-vivo-car-t-cell-therapy-for-relapsedrefractory-b-cell-malignancies/2385835
https://www.manilatimes.net/2026/06/22/tmt-newswire/pr-newswire/carsgen-announces-approval-of-satri-cel-the-worlds-first-car-t-cell-therapy-product-for-solid-tumors/2369996

CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors | The Manila Times

https://www.manilatimes.net/2026/06/22/tmt-newswire/pr-newswire/carsgen-announces-approval-of-satri-cel-the-worlds-first-car-t-cell-therapy-product-for-solid-tumors/2369996